New crystalline form-P of mitapivat sulfate having powder X-ray diffraction pattern at specified diffraction angle for treating hemolytic anemia
	LAKSHMI C V; PRADEEP R; RAMPRASAD A K; NAGARAJU C
	2023-10-07
专利权人	MAITHRI DRUGS PRIVATE LTD (MAIT-Non-standard)
申请日期	2023-10-07
专利号	IN202341067364-A
成果简介	NOVELTY - Crystalline form-P of mitapivat sulfate having peaks (2θ) at 4.4, 8.3, 8.9, 10.8,11.1, 11.9, 12.3, 13.4, 14.9, 16.1, 17.1, 17.5, 18.0, 18.4, 19.7, 20.3, 20.6, 21.4, 22.5, 23.7, 24.5, 25.5, 26.2, 27.4, 27.8, 28.5, 28.9, 29.3, 32.0, 32.2, 33.0, and 33.5±0.2° by powder X-ray diffraction pattern, is new. USE - Crystalline form-P of mitapivat sulfate for treating hemolytic anemia. No biological data given. ADVANTAGE - The crystalline form-P of mitapivat sulfate can be prepared with purity of more than 99% measured by HPLC. DETAILED DESCRIPTION - INDEPENDENT CLAIMS are included for: 1. a method for preparing crystalline form-P of mitapivat sulfate hydrate (8-quinolinesulfonamide, N-[4- [[4(cyclopropylmethyl)-1-piperazinyl] carbonyl]phenyl]sulfate hydrate) (I); and 2. mitapivat sulfate having particle size distribution of D90 of less than 300 μm, D50 of less than 150 μm. and D10 of less than 75 μm.
IPC 分类号	A61K-031/4709 ; A61P-007/06 ; C07D-215/36
国家	印度
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/20103
专题	中国科学院新疆生态与地理研究所
作者单位	MAITHRI DRUGS PRIVATE LTD (MAIT-Non-standard)
推荐引用方式 GB/T 7714	LAKSHMI C V,PRADEEP R,RAMPRASAD A K,et al. New crystalline form-P of mitapivat sulfate having powder X-ray diffraction pattern at specified diffraction angle for treating hemolytic anemia. IN202341067364-A[P]. 2023.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。